[Federal Register Volume 66, Number 167 (Tuesday, August 28, 2001)]
[Notices]
[Page 45340]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-21716]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on February 15, 2001, Cedarburg 
Phamaceuticals, LLC, 870 Badger Circle, Grafton, Wisconsin 53024, made 
application by letter to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of tetrahydrocannabinols (7370), a 
basic class of controlled substance listed in Schedule I.
    The firm will manufacture tetrahydrocannabinols for another firm.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than October 29, 2001.

    Dated: August 20, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-21716 Filed 8-27-01; 8:45 am]
BILLING CODE 4410-09-M